Description
Composition:
(Rifaximin Tablets 550 mg)
Indications:
- Diarrhea associated with IBD / IBS
- Hepatic Encephalopathy
- Traveler’s Diarrhea
- Controls SIBO (Small Intestinal Bacterial Overgrowth)
- Adjuvant therapy in chronic treatment-resistant pouchitis
- Cirrhotic infections
- Functional Dyspepsia
Why REFABER?
- Rifaximin is a non-systemic, broad-spectrum oral antibiotic that binds to the β-subunit of bacterial RNA polymerase, blocking RNA synthesis and bacterial growth.
- Demonstrates both bactericidal and bacteriostatic
- Provides clinically significant relief in patients with IBS-D.
- In traveler’s diarrhea, rifaximin is as effective as ciprofloxacin in reducing duration of unformed stools.
- Reduces recurrence risk in hepatic encephalopathy.
- Approved for treatment of IBS-D in adults with well-established safety.
- Effective as adjunctive therapy in Crohn’s disease and SIBO
Available Strengths:
- REFABER 400 mg
- REFABER 550 mg
Dosage & Administration:
| Indication | Recommended Dose |
| Traveler’s Diarrhea | 400 mg three times daily for 3 days |
| IBS-D (Irritable Bowel Syndrome) | 550 mg three times daily for 14 days (can retreat up to 2 times) |
| Hepatic Encephalopathy | 550 mg twice daily |
Dosage may vary at the discretion of the physician based on patient profile.
Packaging:
- Available in Alu-Alu strips of 10 tablets
- 400 mg and 550 mg strengths available
Reviews
There are no reviews yet.